Tick-borne illness in Australia: rickettsial disease, tick paralysis, alpha-gal

Tick-borne illness in Australia is a clinically heterogeneous subject, shaped by our unique fauna, contested science, and a patient community with strong advocacy. The GP’s first task is to distinguish the five distinct syndromes: rickettsial spotted-fever infection, tick paralysis, alpha-gal mammalian meat allergy, the contested entity DSCATT, and imported Lyme borreliosis from overseas travel. Accurate diagnosis prevents unnecessary antibiotic exposure, ensures appropriate emergency care, and maintains therapeutic trust.

A. Core clinical — the AU general-practice framework

Five distinct clinical entities

1. Australian rickettsial tick-borne disease. Three established spotted-fever-group rickettsioses occur in Australia. Australian tick typhus (Rickettsia australis) is the most common, found in coastal New South Wales and Queensland eucalypt forest, transmitted by Ixodes holocyclus. Flinders Island spotted fever (Rickettsia honei) occurs in Bass Strait, Tasmania, and parts of South Australia, carried by Bothriocroton hydrosauri. All cause vasculitis through endothelial infection. Classic features: fever, severe headache, a black eschar at the bite site, regional lymphadenopathy, and a maculopapular rash that may become vesicular. Per Therapeutic Guidelines (eTG), treat with doxycycline 100 mg twice daily orally for 7–14 days — continue at least 3 days after defervescence. Response within 48–72 hours is the rule; failure to improve should prompt review of the diagnosis. In children under 8 years or in pregnancy, azithromycin or specialist infectious diseases consultation is preferred.

2. Tick paralysis. Ixodes holocyclus on Australia’s east coast produces a salivary neurotoxin (holocyclotoxin) that blocks presynaptic acetylcholine release, causing ascending flaccid weakness. This is predominantly a paediatric emergency — scalp ticks in young children are the classic scenario. Remove the tick by killing it first: spray with an ether-containing aerosol (Wart-Off Freeze, Elastoplast Cold Spray) or permethrin; once dead, remove with fine forceps close to the skin. Pulling a live engorged tick injects more toxin. Admit any child with ascending weakness, bulbar involvement, or respiratory compromise. Equine antitoxin is no longer manufactured. Supportive care including ventilatory support if needed is the mainstay, per the Royal Children’s Hospital Melbourne clinical practice guideline.

3. Alpha-gal syndrome (mammalian meat allergy). IgE sensitisation to galactose-α-1,3-galactose — a carbohydrate present in non-primate mammalian tissue — is triggered by tick bite, predominantly I. holocyclus in Australia. van Nunen and colleagues (MJA 2009) first described this association; Australia is reported to have the world’s highest prevalence. The hallmark is delayed anaphylaxis 3–6 hours after eating mammalian meat (beef, lamb, pork, kangaroo, goat; dairy in some patients). Diagnosis by specific IgE for galactose-α-1,3-galactose. Management per ASCIA: strict avoidance of mammalian meat, two adrenaline auto-injectors, ASCIA Anaphylaxis Action Plan, and clinical immunology referral. Tick-bite prevention reduces ongoing IgE boosting; some patients regain tolerance after years of strict avoidance.

4. DSCATT (Debilitating Symptom Complexes Attributed to Ticks). Formally designated by the Australian Government Department of Health (2018), DSCATT acknowledges a heterogeneous group of patients with prolonged disabling symptoms — fatigue, arthralgia, cognitive disturbance, neuropathic symptoms — attributed by the patient to local tick bite. The 2016 Senate Community Affairs Committee inquiry and the RCPA 2016 position statement both concluded there is no convincing microbiological evidence for locally acquired classic Lyme borreliosis. This contested evidence base requires honest clinical communication — validate the patient’s genuine distress while explaining that long antibiotic courses are not supported by evidence and carry documented harms.

5. Imported Lyme borreliosis. This is a valid diagnosis in patients with documented exposure in endemic areas — the US north-east, central and northern Europe, Scandinavia. Erythema migrans (expanding target rash at bite site) is diagnostic. Per IDSA/AAN/ACR 2020 guidelines (Lantos et al., CID 2021): treat erythema migrans with doxycycline 100 mg twice daily × 10 days, or amoxicillin 500 mg three times daily × 14 days. Early disseminated disease (cranial nerve palsy, carditis) and late Lyme arthritis require longer courses and sometimes IV ceftriaxone. Two-tier testing (ELISA then Western blot) is only appropriate when documented overseas endemic-area exposure exists. Ordering Lyme serology without such exposure produces false positives and misdirected care per the RCPA.

Investigation approach

The investigation choice depends on the clinical syndrome suspected. For rickettsial disease: PCR (ideally within the first 7 days) and paired acute and convalescent serology via Westmead RPA Centre for Infectious Diseases and Microbiology. For alpha-gal: specific IgE for galactose-α-1,3-galactose, total IgE, and tryptase if anaphylaxis. For DSCATT: full comorbidity screen — FBC, UEC, LFT, CRP, ESR, ferritin, B12, vitamin D, TFT, autoimmune screen (ANA, ENA, complement). For imported Lyme only: two-tier ELISA then Western blot in an accredited Australian laboratory.

B. Evidence and clinical controversies

Is classic Lyme borreliosis endemic in Australia? The mainstream Australian position — RCPA 2016, Senate inquiry 2016, ANZSCID — is no. The Lyme Disease Association of Australia disagrees. This is genuine clinical equipoise at the research level; patients are entitled to know both positions exist.

Prolonged antibiotics for DSCATT. Four randomised controlled trials (Klempner, Krupp, Fallon, Berende) found no sustained benefit from prolonged antibiotics in post-treatment Lyme disease syndrome. Documented harms include Clostridioides difficile colitis, central-line associated bloodstream infections, anaphylaxis, and antibiotic resistance. The DoH DSCATT clinical pathway and Australian Prescriber do not endorse long antibiotic courses.

Freeze-first tick removal. ASCIA and RCH Melbourne CPG recommend ether-spray or permethrin to kill I. holocyclus in situ before removal, preventing salivary boost of both holocyclotoxin and alpha-gal antigen.

C. Tick identification and prevention

Key Australian tick species and their geographic ranges. Ixodes holocyclus (paralysis tick) is found within approximately 20 km of the eastern coast from northern Queensland to eastern Victoria, in moist eucalypt scrub. Amblyomma triguttatum (kangaroo tick) is found in Western Australia and South Australia. Bothriocroton hydrosauri (southern reptile tick) is the Flinders Island spotted fever vector in Bass Strait and Tasmania. Haemaphysalis longicornis is a bush tick widespread in the eastern states.

Prevention. DEET 20% or picaridin applied to exposed skin, long clothing with trousers tucked into socks or gaiters, light-coloured clothing (ticks more visible), permethrin-treated clothing, and a full skin check after every bush exposure — paying attention to scalp, axillae, groin, back of neck, and behind ears. These measures reduce both tick attachment and ongoing alpha-gal sensitisation in those already affected.

D. Australian operations

Notification. Rickettsial spotted-fever group infections are notifiable in most Australian jurisdictions — check your state public health unit requirements. Lyme borreliosis is not nationally notifiable given non-endemicity.

MBS items. Standard GP consultations (items 23, 36, 44) apply. For DSCATT patients with prolonged disabling illness, a GP Chronic Conditions Management Plan (item 965) supports multidisciplinary allied health referrals (physiotherapy, exercise physiology, dietetics, psychology, occupational therapy). Mental Health Care Plan (items 2715/2717) is frequently needed for the distress, mood, and anxiety that accompany chronic illness and fractured therapeutic relationships. ATSI Health Assessment (item 715) for First Nations patients.

PBS items. Doxycycline is General Schedule, unrestricted. Azithromycin is General Schedule for children or pregnancy. Adrenaline auto-injectors (EpiPen/EpiPen Jr) are Streamlined Authority PBS for documented anaphylaxis or significant risk. Prolonged or rotating oral or IV antibiotic protocols for “chronic Lyme” or DSCATT are not PBS-funded and not recommended by mainstream Australian clinical guidelines.

Blood donation. Australian Red Cross Lifeblood defers donation for 4 weeks after tick removal, and longer after febrile illness.

E. Special populations

Children. Tick paralysis is almost exclusively paediatric and almost exclusively east-coast. Any child living in or visiting the coastal bush between northern Queensland and eastern Victoria with progressive ascending weakness, facial weakness, or altered breathing after a tick bite requires urgent assessment and admission. Scalp examination is the critical examination step. Doxycycline is accepted for short courses in children under 8 years for rickettsial disease given the severity of the alternative — the dental-staining concern is weighed against potentially life-threatening infection.

Pregnant women. Rickettsial infection in pregnancy warrants specialist infectious diseases input — azithromycin is preferred over doxycycline (Category D in pregnancy). Alpha-gal anaphylaxis in pregnancy requires joint obstetric and allergy management. DSCATT multidisciplinary care continues during pregnancy; no antibiotics are appropriate.

Occupationally exposed workers. Foresters, wildlife handlers, veterinary workers, and environmental scientists are at sustained high risk. DEET or picaridin, permethrin-treated work clothing, and structured post-shift tick checks are essential. Occupational tick exposures may be compensable under workers compensation legislation — document exposures carefully.

Aboriginal and Torres Strait Islander peoples. Outdoor occupation and country-based lifestyle in tick-endemic areas create ongoing exposure. The 715 health assessment provides an opportunity to enquire about tick exposures, past rickettsial illness, and to check alpha-gal IgE in symptomatic individuals.

When to escalate

Refer urgently when:

• Child with ascending weakness, bulbar dysfunction, or respiratory compromise after tick bite — 000 and paediatric emergency
• Suspected alpha-gal anaphylaxis — stabilise, prescribe adrenaline auto-injectors, urgent clinical immunology referral
• Rickettsial illness not responding to doxycycline within 72 hours — infectious diseases input
• Imported Lyme with carditis (AV block) or neurological features — cardiology or neurology involvement
• DSCATT causing severe disability — formal multidisciplinary assessment under a chronic conditions management plan
• Significant psychological distress, suicidality, or severe deconditioning in DSCATT patients

What this article is and is not

This is general health information drawn from current Australian guidelines — Therapeutic Guidelines (eTG), Department of Health DSCATT clinical pathway, ASCIA tick allergy guidance, RCH Melbourne clinical practice guidelines, and the IDSA 2020 Lyme guidelines. It is not personal medical advice and does not create a doctor–patient relationship. Decisions about testing, treatment, and referral are made with your own GP and treating clinicians. The clinical evidence in this area is contested in parts, and both the mainstream position and patient-advocate position are represented above.

For consumer information: HealthDirect — Ticks, Better Health Channel, ASCIA patient information on tick allergy.

---

Sources cited

1. Australian Government DoH — DSCATT clinical pathway (2018)
2. Therapeutic Guidelines (eTG) — Rickettsial infections
3. ASCIA — Tick allergy and alpha-gal syndrome
4. RCH Melbourne — Tick envenomation CPG
5. RCPA — Borreliosis diagnostic testing position statement (2016)
6. Australian Senate Community Affairs Committee — Lyme-like illness inquiry (2016)
7. RACGP
8. NPS MedicineWise
9. HealthDirect — Ticks
10. Better Health Channel
11. van Nunen SA et al. — MJA 2009
12. Lantos PM et al. — IDSA 2020 Lyme disease guidelines. CID 2021
13. Australian Red Cross Lifeblood — donor eligibility